Showing 2161-2170 of 7247 results for "".
Content Marketing for Dermatologists
https://practicaldermatology.com/topics/practice-management/content-marketing-for-dermatologists/20536/A mix of time-sensitive and evergreen content is best to optimize engagement.NRS: New Rosacea Classification; Pediatric Teledermatology; Bleach Baths
https://practicaldermatology.com/series/dermwire-tv/nrs-new-rosacea-classification-pediatric-teledermatology-bleach-baths/18394/There's a new standard classification and pathophysiology of rosacea from the National Rosacea Society. New evidence shows that virtual diagnosis of pediatric dermatologic conditions is feasible. New research suggests that water baths may be just as good as bleach baths for treating eczema. ResearchJanssen Approvals, New Thermage FLX, Restylane Silk Cannulas
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-janssen-approvals-new-thermage-flx-restylane-silk-cannulas/18401/Janssen Biotech's Stelara is now approved for the treatment of adolescents 12 years of age or older with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. Janssen's SIMPONI ARIA® cleared for the treatment of adults with active psoriatic arthritis or activeLyme Disease Update
https://practicaldermatology.com/topics/general-topics/lyme-disease-update/20604/Exploring current thinking about Lyme Disease diagnosis and treatment.Physician Spotlight: Richard Odom, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight/20702/Revelations and reflections on the pathogenesis and etiology of rosacea.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20924/Valeant Business Update; Melanoma Drugs Approved
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-valeant-business-update-melanoma-drugs-approved/18679/In this edition of DermWireTV from the editors of Practical Dermatology® magazine and DermWire.com, we take a look at Valeant's warning of disruption of dermatology business following its break from specialty pharmacy Philidor. Plus, an update on Melanoma Therapeutics, including approvals of ImlygicManaging Pruritus in Geriatric Patients
https://practicaldermatology.com/topics/practice-management/managing-pruritus-in-geriatric-patients/21146/Treatment tips and considerations for this patient population.EGFR Inhibitor-induced Acneiform Rash: A Review of Current Management Strategies
https://practicaldermatology.com/topics/general-topics/egfr-inhibitor-induced-acneiform-rash-a-review-of-current-management-strategies/21517/Understanding Zeltiq
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/understanding-zeltiq/21623/Practical considerations for integrating lasers and energy based devices in a dermatology practice.